XNAS · MLAB
-0.47% · -$0.6000 · Vol 136.7K
Market closed · last close 4:00 PM ET · price as of 16:06:43 ET
Mesa Laboratories Inc

Mesa Laboratories Inc

INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL
$126.54
Card
Relationship Map

Follow $MLAB

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $MLAB by email

Veridion Score

BETAMEDIUM CONF · 6 of 6 factors measuredMethodology
MLAB
Mesa Laboratories Inc
Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET
Upper range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

69/ 100
Veridion Score
Upper range · MEDIUM confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: MEDIUM · 6 of 6 factors measured · Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is MLAB moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading MLAB catalysts
About Mesa Laboratories Inc
INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL
Listed since
1984
Employees
717
Country
US

Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$126.15
Day high
$127.74
Day low
$124.50
Previous close
$127.14
52W high
$130.65
-3.15% from high
52W low
$64.07
94% of range
Market cap
$708.1M
P/E
51.86×
EPS
$2.44
Beta
0.92
Shares out
5.6M
Volume
136.7K
0.87× rel vol
Avg volume
156.8K
VWAP
$126.12
Price history computed in-house
1W
+4.69%
1M
+1.43%
3M
+35.73%
1Y
+73.01%
YTD
+61.20%
SMA 50 $111.97 · above
SMA 200 $96.74 · above
52W position 94%

MLAB overview

Loading financial statements
Loading MLAB Form 4 filings
Public disclosures

Congress activity in MLAB

No receipt-qualified Congressional disclosure is present for MLAB in the cached public ledger.

Federal contracts

MLAB contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for MLAB in this window.
Lobbying spend

MLAB lobbying filings, year to date.

Registered lobbying filings matched to Mesa Laboratories Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for MLAB in this window.
Loading news for MLAB
Analyst ratings
Sovereign unlock shows live analyst consensus for MLAB.
Options
Sovereign unlock shows live options positioning for MLAB.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.